Today: 30 June 2026

Marcin Frąckiewicz

Marcin Frąckiewicz is the founder and CEO of TS2 Space, a satellite communications company serving customers around the world. A graduate of the Warsaw School of Economics (SGH), he has more than two decades of experience in telecommunications, satellite services and technology ventures. He writes about satellite communications, space technology, artificial intelligence and the stock market, with a particular focus on technology companies, semiconductors, emerging industries and the trends shaping global innovation.

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue (KVUE) Stock Plunges Amid Tylenol and Talc Fears – What’s Next?

Kenvue’s stock has been volatile. On Oct 16, 2025 it closed around $15.46, marking a fresh 52-week lowinvesting.com. Over the prior week the shares had slid ~13%, partly driven by jitters over UK talc lawsuits and Trump-era Tylenol claims. Investors bid on options, with call volume surging 52% on Oct 13marketbeat.com, even as the stock dipped 2.9% that day to $16.17marketbeat.com. Year-to-date KVUE is roughly flat to down modestly, but it lags the broader market. For context, the S&P 500 was nearly unchanged while Kenvue was down ~5% on Oct 16. A longer view shows KVUE rose after its 2023 IPO but has struggled through 2024–2025 amid headwinds. Institutionally, Kenvue has a market cap of ~$31 billion and a trailing P/E around 22marketbeat.com. Chart watchers note its 50-day moving average is well above current levelsmarketbeat.com. The sharp recent dips mean many investors wonder if KVUE is “on sale” or if fresh catalysts are needed. The dividend was recently raised to $0.2075 per share, underpinning that 5.1% yieldmarketbeat.com, which helps some income investors tolerate the pullback.
16 October 2025
·
AMD’s AI Mega-Deal Sparks Stock Surge – Inside the OpenAI Partnership, New Chips & Showdown with Rivals

AMD Stock Skyrockets on AI Mega-Deals — Is $300 Next?

AMD’s exhibition stand at Gamescom 2022. AMD has been aggressively showcasing new AI infrastructure and forging partnerships across the industry. As a result, AMD stock has raced higher this month – on Oct. 15 it hit a 52-week intraday high of $240.48 and closed around $238.7marketbeat.com, up over 8% that day. In the past week, the catalyst was two major AI deals. On Oct. 6, AMD announced a multi-year agreement with OpenAI: the chipmaker will supply six gigawatts of high-performance Instinct GPUs to OpenAI’s training data centers, and OpenAI received warrants to buy up to 160 million AMD shares at a nominal pricets2.tech. CEO Lisa Su hailed the arrangement as “win-win, enabling the world’s most ambitious AI buildout”ts2.tech. CFO Jean Hu projected it would “deliver tens of billions of dollars in revenue” and be “highly accretive” to earningsts2.tech. According to AMD, this deal could generate over $100 billion in new revenue over four yearsts2.tech. AMD EVP Forrest Norrod told Reuters the pact is “certainly transformative, not just for AMD but for the dynamics of the industry”reuters.com. OpenAI’s CEO Sam Altman said the chips will allow his team to “build enough AI infrastructure to meet its needs”reuters.com.
16 October 2025
···
Palantir (PLTR) Stock Soars on AI Hype – Is It a Bubble or the Next Tech Giant?

Palantir Stock Skyrockets Again – AI Boom Sparks 300% 2025 Rally (Is a Correction Coming?)

In dollar terms, PLTR’s market cap is about $426 billion – comparable to or exceeding legacy defense primes. However, analysts note the valuation is extremely high: Palantir’s forward price/sales is over 100× and forward P/E above 200×, far above most peersreuters.com. Investors remain bullish for now, expecting continued growth, but such lofty metrics also raise bubble concerns. Palantir’s 2025 surge is underpinned by a steady stream of big deals. In July, the U.S. Army consolidated dozens of projects into a new indefinite-delivery contract worth up to $10 billion over 10 years. In September, the UK Ministry of Defence announced a strategic AI/data partnership with Palantir, promising up to £1.5 billion of investment in UK defence tech and making London Palantir’s European defense HQ. These government deals signal deepening adoption of Palantir’s software in military programs.
16 October 2025
··
Agnico Eagle Mines Stock Soars to New Highs — Gold Boom Fuels Bullish Outlook

Agnico Eagle Mines Stock Soars to New Highs — Gold Boom Fuels Bullish Outlook

Agnico Eagle is trading near its all-time high. On Oct 16, AEM touched $187.09, up +4.7% from the prior closereuters.com. This follows a 16.7% jump over the past month, and the stock is roughly +128% year-to-datefinviz.com. In comparison, broad gold-mining indexes have also risen strongly in 2025, but AEM’s gains are among the largest in the sector. Investors note that AEM’s price has broken key resistance levels; technical screens flag the trend as overwhelmingly positive. Agnico Eagle’s rally is tightly linked to gold’s bull market. Gold prices recently hit record highsreuters.com. Safe-haven demand has lifted metal prices, which in turn boosts miners’ profits per ounce. “Gold has been on a tear, and it doesn’t look like it wants to stop,” says Fawad Razaqzada of FOREX.comreuters.com. With gold up ~60% in 2025, CEOs of major miners are pumping up dividends and paying down debt. AEM, in particular, has a debt/equity of only 0.03 and is increasing capital spending to expand production. Its diversified mines help stabilize output even as high-grade ore plays are developed.
16 October 2025
··
Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont Stock Skyrockets as Gold Rally Hits Record Highs – Will the Boom Continue?

Newmont’s stock is benefiting from this perfect storm of factors. Technically, the chart is exceptionally strong – NEM cleared a golden crossover and trades well above key moving averagesnasdaq.cominvesting.com. Fundamentally, the company is healthy: it beat latest earnings, has low net debt, and the free cash flow to maintain dividends and buy back stocknasdaq.commarketbeat.com. Analysts have lifted estimates accordingly. Zacks notes 2025 EPS consensus is now about $5.50, and Q3 EPS is expected to jump ~58% vs. a year agonasdaq.com. Expert Commentary: Several strategists point to the gold-friendly environment. For example, Bank of America’s Michael Jalonen reiterated a Buy on NEM, lifting the price target to $115gurufocus.com. Validea’s guru-scoring gives NEM mixed marks – the Zweig Growth model scores NEM only 54%, citing weak long-term EPS growth and high debtts2.tech – but also notes recent earnings momentum. In practice, however, most analysts remain constructive: Goldman and BNP upgraded their views earlier this year, Stifel and CIBC rate NEM “strong buy”/“outperform”marketbeat.com. MarketBeat reports Newmont’s consensus target still implies upside vs. today’s ~$90 pricemarketbeat.commarketbeat.com, and firms like Raymond James are raising forecasts.
16 October 2025
··
CoreWeave’s AI Cloud Goldrush: CRWV Stock Skyrockets on Mega-Deals & Bold Moves

CoreWeave (CRWV) Stock Skyrockets on Nvidia-Backed AI Deals – Analysts Eye More Upside

CoreWeave’s stock has jumped sharply on AI-driven growth. A booming GPU data center business and new partnerships have pushed CRWV to record highs in 2025. Investors can see the rally of CoreWeave’s shares in recent charts. The stock tripled from its $40 IPO in March 2025ts2.tech, with a roughly 200% gain by late September after the Meta deal newsts2.tech. On Sept. 30, the Meta announcement alone lifted CRWV about 8% in pre-market trading and to a new intraday recordts2.tech. After a brief pullback in mid-October, renewed deal announcements have sent the price higher againstockanalysis.com. By Oct. 16 the stock was trading in the mid-$140s, up about 5% for the daystockanalysis.com. Overall in early October CRWV’s market cap reached roughly $70–75 billionts2.techts2.tech, making it one of 2025’s top tech performers. CoreWeave’s rise has been fueled by big-name AI partnerships. In late September, it landed a $14.2 billion multi-year deal to supply GPU cloud capacity to Meta Platformsts2.tech. CoreWeave CEO Michael Intrator said Meta “loved our infrastructure in earlier contracts and came back for more,” reflecting confidence in CoreWeave’s technologyts2.tech. Just days earlier it expanded its partnership with OpenAI by another $6.5 billion, bringing OpenAI’s total commitments to about $22.4 billion for
16 October 2025
··
Apple Stock Hits New Heights: iPhone 17 Supercycle, Analyst Split, and 2025 Outlook Revealed

Apple Stock Update: New AI Chip News Sparks Bull-Bear Battle for $AAPL

As of the Oct. 16 session, Apple shares were trading around $247, roughly 1% below Wednesday’s close. The stock has edged up over the past week – trading above both its 50- and 200-day moving averages – but remains below its Sept. high near $260marketbeat.comts2.tech. Volume has been moderate. Market observers note that Apple briefly rallied on Oct. 15 when the company released its M5 chip newsts2.tech, but profit-taking and broader profit-taking in tech pulled AAPL down on Thursday. For context, major indexes were mixed: the Nasdaq 100 and S&P 500 saw slight gains on Wednesday, fueled by robust bank earnings and AI chip strength. Apple’s share movement today largely reflects a pause in that rally. One analyst notes Apple’s rich valuation means “upside is modest” unless new catalysts emergets2.tech.
16 October 2025
·
The $350B Shake-Up: How AI Summaries Rewire Publisher Traffic

Alphabet (GOOGL) Stock Skyrockets on AI & Ad Revival – Could $300 Be Next?

Wall Street’s technical indicators and fundamentals have brightened. As one analyst noted, “Alphabet’s stock flirts with record highs” – shares closed around $245 on Oct. 14, near an all-time hights2.tech. Most brokerages now rate GOOGL a Buy. TS2.tech reports BMO Capital Markets citing Alphabet’s “AI leadership” in justifying its $294 targetts2.tech. Scotiabank similarly pointed to a “clear recovery” in advertising when boosting its target to $310za.investing.com. Even Morgan Stanley, UBS and other firms have raised targets modestly, noting that improving ad spending and AI gains warrant higher valuations. MarketBeat summarizes 35 analysts as a “Moderate Buy,” but notes the range of targets is widemarketbeat.com. TipRanks’ data is more uniformly positive: 38 analysts on its platform average a $258.81 targettipranks.com. In short, the consensus is bullish, though targets vary with some caution on valuation. Alphabet’s recent announcements underscore why investors are excited. The company is plowing tens of billions into AI data centers and chips. Just in the past week Alphabet unveiled a $15B AI data center project in India and a $9B U.S. data center expansionts2.tech. It also upgraded its AI tools – for example, Google announced Veo 3.1 and a 27B-parameter “Gemma” model for scientific researchza.investing.com. These efforts are
16 October 2025
··
Battle of the EV Charging Standards: Tesla’s NACS vs. CCS2 vs. CHAdeMO – Who Will Rule the Roads in 2025?

Tesla Stock’s Wild Ride: Soars on Record Deliveries, Then Sags After Budget EV Reveal

Tesla’s mid-October stock action reflects this mix of good news and looming questions. On Oct 16, 2025, TSLA traded roughly flat in the mid-$430sreuters.com. That mild move belied a wildly volatile week. After hitting multi-month highs around $453 in early October, Tesla gave back ground on profit-taking. “Tesla’s stock has seesawed sharply,” noted our research: it surged ~5.4% on Oct 6, then plunged 4.5% on Oct 7, jumped again on Oct 13, and slid ~1.5% on Oct 14ts2.techts2.tech. Most recently, around Oct 10–14 the stock fell on a broad tech selloff and trade worries, then rebounded with the market on Oct 13 before softening again on Oct 14ts2.techts2.tech. This October “rollercoaster” was largely news-driven. It began with Tesla’s blockbuster Q3 delivery report. On Oct 2, Tesla announced it had delivered 497,099 cars in the quarter – an all-time quarterly high and well above forecaststs2.tech. Management and Wall Street hailed the number, but there was an asterisk: most of the jump was driven by a one-time rush as buyers raced to beat the Sep 30 expiry of the $7,500 U.S. EV tax creditts2.tech. Tesla slashed prices and offered special financing in Q3 to pull forward sales – essentially “borrowing” demand from
16 October 2025
··
Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar (NASDAQ: KYIV) Stock Rockets on 5G Upgrade Plans and Mastercard Tie-Up

Kyivstar’s share price has been volatile since its historic Nasdaq debut. In August, the IPO raised $178 millionreuters.com, valuing the company around $2.6 billion. Initial trading saw a sharp swing: the stock opened around $13–14, then peaked at nearly $16 on Aug. 20 before sliding. By mid-September it had fallen to about $11.25kyivpost.com. ICU Investment Group trader Vitaliy Syvach commented that “after the initial excitement came a more sober assessment” of Kyivstar’s growth prospectskyivpost.com. Indeed, some profit-taking and broader market volatility dampened the early rally. However, new corporate initiatives in October have given the stock a boost. On Oct. 6, Kyivstar announced a large-scale network modernization project running through 2025–2026 to upgrade infrastructure and prepare for 5G deploymentnasdaq.com. The press release noted that sites already updated have seen about 30% faster data speeds and 50% more capacitynasdaq.com. Analysts say such investments can drive subscriber growth and revenue over time. Then on Oct. 15, Kyivstar disclosed a Memorandum of Cooperation with Mastercard: the two will develop fintech solutions and even test Starlink satellite-to-cell connectivity in payment systemsglobenewswire.com. This partnership is designed to “strengthen the resilience of the country’s financial infrastructure, promote cashless payments, and expand access to financial services,” according to
16 October 2025
··
Plug Power Stock Explodes 170% on Analyst Hype & Giant Hydrogen Deal

Plug Power (PLUG) Stock Skyrockets on Hydrogen Hype – Is PLUG a Buy or Bubble?

PLUG’s October rally caught Wall Street’s eye. After slipping for much of 2025, the stock surged in early October as analysts turned bullish and hydrogen demand news broke. For example, H.C. Wainwright on Oct. 3 raised PLUG’s price target from $3 to $7 and maintained a Buy ratingmarketbeat.com, and HSBC upgraded Plug to a “Strong Buy” on Oct. 9marketbeat.com. These upbeat calls came as the company announced its first big electrolyzer delivery in Europe. The result: Plug’s shares nearly doubled since early September, trading around $4.05 by Oct. 14ts2.tech – near a 52-week high – before a modest pullback. Despite the recent rally, analysts remain divided on PLUG. Market data show one strategist now calls it a “Strong Buy,” five have Buy ratings and seven are Hold, while six still rate it Sellmarketbeat.com. Notably, the average 12-month price target is only about $2.47marketbeat.com, far below current levels, suggesting many experts see limited upside or even downside risk. As one market commentary noted, the Oct. 15 pullback came after an unsustainable ~150% surge in weeks prior, reflecting “deeper concerns about the company’s financial health”markets.financialcontent.com.
16 October 2025
·
NVIDIA 2025: Dominating the AI Boom – Company Overview, Key Segments, Competition, and Future Outlook

Nvidia Stock Skyrockets on $100B AI Deal – Will NVDA Hit $320 Target?

Nvidia’s stock is trading high in October 2025. It closed at $184.87 on Oct. 15investing.com, up slightly from the prior day, and was around $180–183 in early trading on Oct. 16reuters.com. The week of Oct. 10–16 saw some profit-taking: NVDA hit an intraday high near $195 on Oct. 10investing.com, then retreated into the low-$180s, but remains well above levels from earlier in 2025. Overall, Nvidia is up roughly 30% YTD, vastly outperforming the S&P 500ts2.tech. Trading volumes have been heavy, reflecting strong investor interest. Several factors are driving the recent moves. In late September, Nvidia hit record highs on major AI newsts2.tech, then eased back as tech stocks broadly corrected. Analysts note that “high valuations and interest-rate jitters” have spurred some profit-taking in growth stocks, including NVDAts2.tech. Still, most observers see the pullback as a breather. As of mid-October, NVDA trades at roughly 50× forward earningsts2.tech – expensive, but analysts argue the booming AI outlook justifies it.
16 October 2025
···
Billionaire-Backed Crypto Bank Approved by Regulators – Are Tech Stocks and Crypto Ready to Soar?

Billionaire-Backed Crypto Bank Approved by Regulators – Are Tech Stocks and Crypto Ready to Soar?

The OCC’s approval letter makes Erebor the first new charter since Gould took over in June 2025benzinga.com. In announcing the decision, Gould stressed that innovative banks need not be blocked: “Permissible digital asset activities… have a place in the federal banking system if conducted in a safe and sound manner,” he saidbenzinga.com. This is a notable change of tone from prior OCC leadership. As Benzinga reports, the OCC applied its usual rigorous standards but ultimately concluded Erebor’s plan was sound, making it “the first de novo bank to receive preliminary approval under Gould’s tenure”benzinga.com. Despite the approval, the OCC letter makes clear the bank cannot open for business immediately. All pre-opening conditions must be met: obtaining FDIC insurance, finalizing a board with qualified executives, establishing cybersecurity and compliance systems, and maintaining high capital buffersholder.iobenzinga.com. The charter mandate specifically requires a roughly 12% Tier‑1 leverage ratio in the first three yearsholder.iobenzinga.com. Only after these steps will the OCC give final sign-off.
16 October 2025
··
Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

Oracle Stock Surges on $300B AI Cloud Deal – Is a Trillion-Dollar Valuation Next?

As of Oct. 16, Oracle is trading near $304 per share. Investing.com data show ORCL closed at $303.98 on Oct. 16investing.com. This comes after a volatile week: the stock hit an all-time intraday high on Sept. 10ts2.tech following the AI cloud deal announcements, then pulled back 15–20% by early October on profit-taking and margin concernsts2.techts2.tech. Overall, ORCL is up roughly 70% year-to-date, far outperforming the broader tech sector and even leaving Microsoft and Alphabet in the dustts2.tech. Even mid-month blips have barely dented the stock, which remains historically high. Earnings and AI contracts: In the Sept. 9 earnings call, Oracle posted revenue of $14.93 billion with cloud sales up 28%reuters.com. The company confirmed that four huge cloud infrastructure contracts were signed, collectively worth “many billions,” and noted that three customers were involved – implying one or more repeat dealsreuters.com. Notably, news outlets reported one of these customers is OpenAI, which is reported to have agreed to purchase about $300 billion of Oracle Cloud compute over 5 yearsreuters.comreuters.com. This single deal would be one of the largest in history and explains much of Oracle’s current hype. CEO Safra Catz said on the call: “Over the next few months, we expect to
16 October 2025
····
Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance Bancorp Stock Plunges on First Brands Fallout — Analysts See Upside

Western Alliance’s stock has been volatile recently. After rallying through summer, it tumbled in early October. On Oct 8, WAL fell about 4% amid headlines that a Jefferies-managed fund held ~$715 million in First Brands receivablests2.techmlq.ai. By Oct 15, WAL closed near $78.84, down ~4% for the dayinvesting.com. Trading volume surged as investors digested the news. A day later, Reuters reported WAL shares were still down ~5.4%reuters.com, despite the bank’s reassurances. Management disclosed it had filed a fraud lawsuit related to one credit and said its “criticized assets” actually fell from June to Septreuters.com. These efforts helped “pare losses” on Oct 16reuters.com, but the stock remained well below recent highs. The sharp swing is largely driven by First Brands Group’s collapse. First Brands, an auto-parts supplier, filed Chapter 11 in late Sept with $10–$50 billion of liabilitiests2.tech. TS2 Tech reported that First Brands immediately drew $1.1 billion in DIP financing to keep runningts2.tech. Crucially, First Brands had quietly amassed large off-balance-sheet debts and had sold factored receivables to finance buyers. Jefferies was First Brands’ main lender for years; its Point Bonita fund holds roughly $715M of First Brands–backed receivablests2.tech – nearly 25% of that fund’s $3B portfolio. These receivables were
16 October 2025
·
Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Scienture (SCNX) Stock Skyrockets on New FDA-Approved Blood Pressure Drug Launch

Pills and a daily pill organizer: Arbli’s liquid formulation helps patients who can’t swallow tablets. Scienture’s stock jumped sharply on Oct. 16 after the company formally launched Arbli™ in the U.S. market. In a GlobeNewswire press release that morning, Scienture announced that Arbli™ is now shipping through major pharmaceutical wholesalers nationwideglobenewswire.com. Arbli is the first FDA-approved oral liquid form of losartan, a top-selling blood pressure drug. The launch news and accompanying marketing caused traders to bid up SCNX: one trader wrote that shares moved “from yesterday’s close around 72 cents to nearly 95 cents” on the newsragingbull.com. By mid-day, Reuters reported SCNX trading near $0.71, up ~30% from the prior closereuters.com. President Narasimhan Mani highlighted that the launch “opens access to a meaningful new patient segment” and “not only [drives] near-term revenue growth, but also validates our strategy to bring innovative, patient-focused formulations to multiple therapeutic categories”globenewswire.com. Similarly, Executive Chairman Shankar Hariharan called the rollout “a paradigm shift… by making Arbli™ available through major wholesalers, ensuring pharmacies and providers can immediately access this breakthrough therapy”globenewswire.com. These statements emphasize how Scienture is converting its FDA approval into real sales.
16 October 2025
··
Virgin Galactic SPCE Stock Surges on Lawsuit Settlement and Purdue Mission News

Virgin Galactic SPCE Stock Surges on Lawsuit Settlement and Purdue Mission News

Virgin Galactic’s share price has been in a prolonged slump, though recent news has sparked a bounce. On Oct. 1, 2025 SPCE closed at $3.42 ts2.tech; by Oct. 16 it had rallied to about $4.89 Investing. The stock traded in a rough range of $3.30–$3.70 through early Oct ts2.tech. Over 2025 the stock is still down roughly one-third, well underperforming the S&P500. SPCE remains extremely volatile. Financially, Virgin Galactic remains pre‑revenue. Q2 2025 results showed just $406K in sales and a $67.3M net loss ts2.tech. The loss per share was narrower than Wall Street feared; MarketBeat notes VG “reported an EPS of… outperforming analysts’ expectations” Marketbeat, although revenue fell short of forecasts. Capital expenditures rose as VG invests in its Delta‑class fleet ts2.tech. Free cash flow was highly negative but operating expenses are down ~34% from a year ago Edgen. Cash reserves were ~$508M at quarter’s end ts2.tech Edgen, bolstered by a $56M equity raise. With ~100–125M spent per quarter ts2.tech Edgen, management projects ~18 months of runway absent new funding. Management still targets a Delta‑class launch by late 2026, but admits the timeline has repeatedly slipped ts2.tech.
16 October 2025
··
GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL Inc. Stock Rises on Samsung Partnership and Cancer-Test News

GRAIL’s shares surged after it announced a deal on Oct. 16 to partner with Samsung in Asia. The binding Letter of Intent involves Samsung C&T and Samsung Electronics investing $110 million in GRAIL at $70.05 per share, with Samsung C&T to distribute the Galleri multi-cancer screening test in South Koreainvesting.comprnewswire.com. This collaboration gives Samsung “a strong foothold for expanding into the cancer screening field”, according to Jaywoo Kim, EVP of Samsung C&Tprnewswire.com. GRAIL’s President of International Business, Sir Harpal Kumar, said the deal “strengthens our balance sheet and provides further cash runway” as the company advances toward test reimbursement globallyinvesting.comprnewswire.com. Under the LOI, definitive agreements are expected in early 2026, with testing operations to begin soon after closingprnewswire.cominvesting.com. According to Reuters/Investing.com coverage, GRAIL stock “surged 20%” intraday on the newsinvesting.com. The investment price also sets a benchmark valuation – it was about a 15% premium to the prior closing price. Trading platforms noted that with this move, GRAIL had risen more than fourfold year-to-datetradingview.com. The Samsung pact comes on the heels of GRAIL’s earlier expansion deals: in mid-2025 GRAIL teamed up with Everlywell to make Galleri available via prescription on Everlywell’s platformprnewswire.com, and Rush University began offering Galleri testing under
16 October 2025
···
J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt (JBHT) Stock Soars on Earnings Surprise – Is a Freight Sector Revival Underway?

J.B. Hunt’s stock rallied hard on Oct. 16. Reuters reported that JBHT shares “rose nearly 16% in early trading on Thursday” after the company’s cost-cutting drove a stronger-than-expected profitreuters.com. Traders noted a similar jump according to market news on StockTwitsstocktwits.com. The surge pushed JBHT to multi-week highs as investors reacted to the Q3 results and upbeat comments from analysts. The broad market backdrop also helped: easing China trade worries and hopes for Fed rate cuts lifted U.S. stocks on Oct. 15–16ts2.tech. In this environment, trucking firms with upside surprises got rewarded. As TS2.tech noted, even industrial names like J.B. Hunt saw double-digit gains amid earnings beatsts2.tech. Indeed, JBHT’s jump outpaced many peers – a sign that investors are giving credit to its execution.
16 October 2025
··
Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk Therapeutics Stock Rockets on AI Partnership – What Investors Need to Know

Whitehawk’s stock popped dramatically on Oct. 16 after news of the Tempus collaboration. Shares had been around $2 per share in mid-Octoberstockinvest.us, but the new AI partnership sent them soaring in early trading. By mid-day Oct. 16, various data sites showed WHWK up roughly 50–67% on the sessioninvesting.com. The sudden jump reflects investor excitement about the Tempus deal, which was announced in a press release on Oct. 16marketscreener.com. The Tempus AI collaboration was officially billed as a “multi-year” partnership to use Tempus’s de-identified, multimodal clinical data to improve Whitehawk’s ADC drug developmentmarketscreener.com. In practice, this means Whitehawk will apply Tempus’s large real-world patient database and AI analytics to design smarter clinical trials and identify the patients most likely to benefit from its ADCsmarketscreener.combusinesswire.com. Tempus’s COO, Ryan Fukushima, said that pairing “Tempus’ comprehensive, multimodal data” with Whitehawk’s ADC expertise creates “a powerful foundation” for validating Whitehawk’s cancer targetsmarketscreener.com. Whitehawk’s CEO, Dr. Dave Lennon, added that the goal is to “better understand the expression of our ADC protein targets” using data-driven insights to prioritize which cancers to target firstmarketscreener.com. In other words, instead of relying solely on lab tests of tumor samples, the partnership will use large-scale RNA and clinical data to
16 October 2025
·
1 … 269 270 271 272 273 … 397

Stock Market Today

  • Dow, S&P 500, Nasdaq Futures Edge Higher Before Open
    June 30, 2026, 4:14 AM EDT. Futures for the Dow, S&P 500 and Nasdaq traded higher before the bell, pointing to more gains after a solid first half. Palantir, Micron, Comcast and Nvidia were active. Some traders watch political news tied to Trump and Iran, which has kept the mood cautiously optimistic.
Go toTop